追蹤
David M. Mauger
David M. Mauger
Director of Data Science, Arrakis Therapeutics
在 arrakistx.com 的電子郵件地址已通過驗證
標題
引用次數
引用次數
年份
mRNA structure regulates protein expression through changes in functional half-life
DM Mauger, BJ Cabral, V Presnyak, SV Su, DW Reid, B Goodman, K Link, ...
Proceedings of the National Academy of Sciences 116 (48), 24075-24083, 2019
3582019
Exploring RNA structural codes with SHAPE chemistry
KM Weeks, DM Mauger
Accounts of chemical research 44 (12), 1280-1291, 2011
1602011
hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc
DM Mauger, C Lin, MA Garcia-Blanco
Molecular and cellular biology 28 (17), 5403-5419, 2008
1542008
A requirement for the Saccharomyces cerevisiae Paf1 complex in snoRNA 3′ end formation
KE Sheldon, DM Mauger, KM Arndt
Molecular cell 20 (2), 225-236, 2005
1372005
Functionally conserved architecture of hepatitis C virus RNA genomes
DM Mauger, M Golden, D Yamane, S Williford, SM Lemon, DP Martin, ...
Proceedings of the National Academy of Sciences 112 (12), 3692-3697, 2015
1272015
MicroRNAs enable mRNA therapeutics to selectively program cancer cells to self-destruct
R Jain, JP Frederick, EY Huang, KE Burke, DM Mauger, EA Andrianova, ...
Nucleic acid therapeutics 28 (5), 285-296, 2018
1072018
The genetic code as expressed through relationships between mRNA structure and protein function
DM Mauger, NA Siegfried, KM Weeks
FEBS letters 587 (8), 1180-1188, 2013
622013
IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance
YF Lu, DM Mauger, DB Goldstein, TJ Urban, KM Weeks, SS Bradrick
Scientific reports 5 (1), 16037, 2015
592015
Characterization of the intronic splicing silencers flanking FGFR2 exon IIIb
EJ Wagner, AP Baraniak, OM Sessions, D Mauger, E Moskowitz, ...
Journal of Biological Chemistry 280 (14), 14017-14027, 2005
542005
Fas-activated serine/threonine phosphoprotein (FAST) is a regulator of alternative splicing
M Simarro, D Mauger, K Rhee, MA Pujana, NL Kedersha, S Yamasaki, ...
Proceedings of the National Academy of Sciences 104 (27), 11370-11375, 2007
512007
Polynucleotide secondary structure
D Mauger, I McFadyen, V Presnyak
US Patent App. 16/483,012, 2020
422020
Analysis of RNA nearest neighbor parameters reveals interdependencies and quantifies the uncertainty in RNA secondary structure prediction
J Zuber, BJ Cabral, I McFadyen, DM Mauger, DH Mathews
Rna 24 (11), 1568-1582, 2018
312018
Toward global RNA structure analysis
DM Mauger, KM Weeks
Nature biotechnology 28 (11), 1178-1179, 2010
262010
TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2
HN Yeowell, LC Walker, DM Mauger, P Seth, MA Garcia-Blanco
Journal of investigative dermatology 129 (6), 1402-1411, 2009
212009
The identification of factors regulating the alternative splicing of the FGFR2 transcript in epithelial cells
DM Mauger
Duke University, 2007
12007
High fidelity in vitro transcription
D Mauger, V Presnyak, AE Rabideau, I McFadyen
US Patent 11,851,694, 2023
2023
Polynucleotide secondary structure
D Mauger, I McFadyen, V Presnyak
US Patent App. 18/093,119, 2023
2023
Nuclear proteins TIA and PTB regulate the alternately-spliced long transcript of lysyl hydroxylase 2 that is increased in scleroderma
P Seth, LC Walker, DM Mauger, MA Garcia-Blanco, HN Yeowell
JOURNAL OF INVESTIGATIVE DERMATOLOGY 128, S121-S121, 2008
2008
Factors affecting splicing of scleroderma-associated LH2 mRNA
P Seth, LC Walker, DM Mauger, MA Garcia-Blanco, HN Yeowell
Matrix Biology, 60, 2008
2008
Identification of elements regulating the alternate splicing of Lysyl Hydroxylase 2 (LH2) using a functional 353bp LH2 minigene construct
HN Yeowell, LC Walker, MA Overstreet, A Siddiqui, DM Mauger, ...
JOURNAL OF INVESTIGATIVE DERMATOLOGY 126, 77-77, 2006
2006
系統目前無法執行作業,請稍後再試。
文章 1–20